Funding opportunities
2,259 live opportunities from Grants.gov, NIH, NSF, and more.
Biomedical & Health× remove
- Investigating the role of ZBTB7A in AML differentiationNational Cancer InstitutePA-25-301 closes 5/31/2031up to $543,984activenih
- Reframing BRCA1 Function: A Coordinator of Lagging Strand SynthesisNational Cancer InstitutePA-25-301 closes 5/31/2031up to $469,628activenih
- A Predictive Framework for Human Infection Risk: Genomic Characterization of Vibrio spp. in the Context of Algal Blooms and Extreme Weather EventsNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $741,023activenih
- Semaglutide Dose Effects on Metabolic and Stress Hormones, Craving and Alcohol Use OutcomesNational Institute on Alcohol Abuse and AlcoholismPA-25-305 closes 5/31/2031up to $752,580activenih
- Intrarenal Complement Activation as a marker of kidney injury and treatment response in lupus nephritisNational Institute of Arthritis and Musculoskeletal and Skin DiseasesPA-24-185 closes 5/31/2031up to $177,984activenih
- The molecular mechanisms underlying PHF6-mutation-mediated hematologic malignanciesNational Cancer InstitutePA-25-301 closes 5/31/2031up to $544,988activenih
- Digestive Disease Training ProgramNational Institute of Diabetes and Digestive and Kidney DiseasesPA-25-168 closes 5/31/2031up to $136,736activenih
- Functional Genomic Mapping of Gene Vulnerability in Mycobacterium abscessus Across Host-Relevant EnvironmentsNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $667,659activenih
- Developing next-generation mass spectrometric platforms for molecular cartography of the cellular membranesNational Institute of General Medical SciencesPAR-22-180 closes 5/31/2031up to $304,970activenih
- Effect of Bundling Home-Based Self-Collection for Cervical and Colorectal Cancer Screening: The My Body, My Test-4 TrialNational Cancer InstitutePAR-25-167 closes 5/31/2031up to $645,317activenih
- A Randomized Trial of REFRAME: an Emotion Regulation Intervention to Improve Psychological Outcomes in Surrogate Decision-Makers of the Critically IllNational Institute on AgingPA-25-305 closes 5/31/2031up to $659,056activenih
- Personalizing Post Surgical Thromboprophylaxis for Elderly Patients with Peripheral Artery DiseaseNational Institute on AgingPAR-25-222 closes 5/31/2031up to $802,936activenih
- Lung cancer subtype risk stratification: Validation in real world cohortsNational Cancer InstitutePA-25-301 closes 5/31/2031up to $714,192activenih
- Clonal hematopoiesis as a targetable mechanism of resistance to therapy in thyroid cancer.National Cancer InstitutePA-25-301 closes 5/31/2031up to $752,808activenih
- Advancing Renal Mass Diagnosis and Management through AI-Enhanced Decision Support Systems (RMM-DSS)National Cancer InstitutePA-25-301 closes 5/31/2031up to $632,670activenih
- Identifying individual clinical and environmental predictors of buprenorphine response to inform treatment for opioid use disorderNational Institute on Drug AbusePA-24-185 closes 5/31/2031up to $194,206activenih
- Antibiotics-associated microbiota and functional changes in immune-mediated enterocolitis.National Institute of Allergy and Infectious DiseasesPA-24-182 closes 5/31/2031up to $184,030activenih
- Unraveling shared and unique mechanisms of autoimmunity using systems immunology approaches: Regulatory T cell dysfunction in LupusNational Institute of Arthritis and Musculoskeletal and Skin DiseasesPA-24-182 closes 5/31/2031up to $165,240activenih
- Second-generation new-chemical-entity nanomedicine to target treatment resistance in pancreatic cancerNational Cancer InstitutePA-25-301 closes 5/31/2031up to $667,482activenih
- Role of tumor biomechanics on drug-receptor engagementNational Cancer InstitutePA-25-301 closes 5/31/2031up to $648,579activenih
- Pathways for Regulatory Innovation and Strategic Modernization (PRISM)Food and Drug AdministrationRFA-FD-26-007 closes 5/31/2031up to $1,299,114activenih
- Optimization of a public neoantigen-based cancer prevention strategyNational Cancer InstitutePA-25-301 closes 5/31/2031up to $659,570activenih
- The impact of the cord blood methylome on early-onset pediatric atopic dermatitisNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $784,314activenih
- Immune reprogramming with bioengineered scaffolds for the treatment of biofilm infectionNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $762,758activenih
- Modeling bone metastasis and tumor dormancy in prostate cancerNational Cancer InstitutePAR-25-130 closes 5/31/2031up to $820,855activenih